Literature DB >> 3252240

Animal depression model by neonatal clomipramine: reduction of shock induced aggression.

G Vogel1, P Hartley, D Neill, M Hagler, D Kors.   

Abstract

Clomipramine, administered to neonatal rats, has been reported to produce adult behavioral and REM sleep abnormalities. They include decreased sexual behavior, increased ambulation in the outer part of an open-field arena, increased REM sleep % of total sleep time, and in descriptive data, short REM latency, and increased REM phasic events. Since these abnormalities resemble some found in human endogenous depression, we have hypothesized that the adult rats represent an animal model of depression. Diminished aggressive behavior is a common characteristic of endogenous depression. This study tested the validity of the animal depression model by determining in rats the effect of neonatal clomipramine on adult shock-induced fighting. Experimental rats were treated neonatally with clomipramine and control rats were treated neonatally with saline. When they matured, compared with control rats, experimental rats had significantly fewer offensive fighting responses, and significantly more defensive fighting responses. The findings add some support to the validity of the animal depression model produced by neonatal clomipramine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3252240     DOI: 10.1016/0091-3057(88)90319-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

1.  Dose-dependent effects of neonatal SSRI exposure on adult behavior in the rat.

Authors:  Sharonda S Harris; Dorota Maciag; Kimberly L Simpson; Rick C S Lin; Ian A Paul
Journal:  Brain Res       Date:  2011-10-20       Impact factor: 3.252

2.  Alterations in the levels of monoamines in discrete brain regions of clomipramine-induced animal model of endogenous depression.

Authors:  M Vijayakumar; B L Meti
Journal:  Neurochem Res       Date:  1999-03       Impact factor: 3.996

3.  Effects of neonatal clomipramine on cholinergic receptor sensitivity and passive avoidance behavior in adult rats.

Authors:  J Prathiba; K B Kumar; K S Karanth
Journal:  J Neural Transm Gen Sect       Date:  1995

4.  Effects of chronic treatment with zimelidine and REM sleep deprivation on the regulation of raphe neuronal activity in a rat model of depression.

Authors:  C Maudhuit; M Hamon; J Adrien
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

5.  Effects of monoamine uptake inhibitors given early postnatally on monoamines in the brain stem, caudate/putamen and cortex, and on dopamine D1 and D2 receptors in the caudate/putamen.

Authors:  I Hilakivi; L Ahtee; J O Rinne; T Taira; L M Attila; P Marjamaki
Journal:  J Neural Transm Gen Sect       Date:  1995

6.  Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy.

Authors:  Ouissame Mnie-Filali; Céline Faure; Laura Lambás-Señas; Mostafa El Mansari; Hassina Belblidia; Elise Gondard; Adeline Etiévant; Hélène Scarna; Anne Didier; Anne Berod; Pierre Blier; Nasser Haddjeri
Journal:  Neuropsychopharmacology       Date:  2011-02-16       Impact factor: 7.853

7.  Effects of the altered serotonergic signalling by neonatal treatment with 5,7-dihydroxytryptamine, ritanserin or clomipramine on the adrenocortical stress response and the glucocorticoid receptor binding in the hippocampus in adult rats.

Authors:  T Ogawa; M Mikuni; Y Kuroda; K Muneoka; K J Mori; K Takahashi
Journal:  J Neural Transm Gen Sect       Date:  1994

8.  Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity.

Authors:  Thibaut Sesia; Brandon Bizup; Anthony A Grace
Journal:  Int J Neuropsychopharmacol       Date:  2013-01-29       Impact factor: 5.176

9.  Lasting neurobehavioral abnormalities in rats after neonatal activation of serotonin 1A and 1B receptors: possible mechanisms for serotonin dysfunction in autistic spectrum disorders.

Authors:  Nidhi Khatri; Kimberly L Simpson; Rick C S Lin; Ian A Paul
Journal:  Psychopharmacology (Berl)       Date:  2013-08-24       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.